当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析 - 利润表

九洲药业

(603456)

  

流通市值:137.02亿  总市值:137.02亿
流通股本:8.76亿   总股本:8.76亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入3,936,684,934.672,575,246,576.121,200,661,700.095,508,595,171.33
  营业收入3,936,684,934.672,575,246,576.121,200,661,700.095,508,595,171.33
二、营业总成本3,161,855,661.82,064,924,507.55977,467,580.384,293,596,413.64
  营业成本2,512,535,927.181,625,176,975.78763,953,073.53,478,574,735.98
  税金及附加50,474,542.6633,247,353.0217,852,373.9773,010,518.7
  销售费用83,044,994.0460,228,032.9428,718,357.83107,677,996.07
  管理费用292,897,616.01200,426,264.76103,180,596.61393,892,861.08
  研发费用199,121,583.04129,591,818.4556,238,005.87256,985,924.21
  财务费用23,780,998.8716,254,062.67,525,172.6-16,545,622.4
  其中:利息费用3,407,750.222,475,787.121,353,703.810,124,312.57
  其中:利息收入18,276,930.8312,925,371.416,096,023.2641,316,673.88
三、其他经营收益
  加:投资收益17,220,370.9610,161,121.375,061,216.963,555,802.23
  资产处置收益-4,395,108.93-2,795,632.28-834,740.04-5,159,651.38
  资产减值损失(新)-43,969,136.32-37,944,608.09-13,621,086.35-337,761,490.03
  信用减值损失(新)-8,604,016.87-7,523,210.97-3,516,604.0814,504,746.6
  其他收益24,743,667.8414,989,373.659,555,579.8734,807,092.33
四、营业利润759,825,049.55487,209,112.25219,838,486.07924,945,257.44
  加:营业外收入1,260,525.45767,282.86141,674.931,626,062.06
  减:营业外支出3,199,197.822,545,938.38122,293.547,119,920.98
五、利润总额757,886,377.18485,430,456.73219,857,867.46919,451,398.52
  减:所得税费用150,927,206.04104,736,434.151,586,944.26190,908,281.04
六、净利润606,959,171.14380,694,022.63168,270,923.2728,543,117.48
(一)按经营持续性分类
  持续经营净利润606,959,171.14380,694,022.63168,270,923.2728,543,117.48
(二)按所有权归属分类
  归属于母公司股东的净利润616,782,386.85387,393,043.36172,084,196.97730,073,370.43
  少数股东损益-9,823,215.71-6,699,020.73-3,813,273.77-1,530,252.95
  扣除非经常损益后的净利润615,132,286.68386,203,630.18168,770,734.87729,026,847.84
七、每股收益
  (一)基本每股收益0.690.440.190.82
  (二)稀释每股收益0.690.440.190.82
八、其他综合收益-21,875,959.92-17,745,125.97-8,776,591.02-1,972,075.01
  归属于母公司股东的其他综合收益-21,875,959.92-17,745,125.97-8,776,591.02-1,972,075.01
九、综合收益总额585,083,211.22362,948,896.66159,494,332.18726,571,042.47
  归属于母公司股东的综合收益总额594,906,426.93369,647,917.39163,307,605.95728,101,295.42
  归属于少数股东的综合收益总额-9,823,215.71-6,699,020.73-3,813,273.77-1,530,252.95
公告日期2026-10-222026-08-042026-04-242026-04-24
审计意见(境内)标准无保留意见
TOP↑